About Germitec
Germitec is a company based in Bordeaux (France) founded in 2005 by Clement Deshays.. Germitec has raised $41.59 million across 2 funding rounds from investors including Eurazeo, Kurma Partners and Financiere Arbevel. Germitec offers products and services including Chronos, Antigermix, and Yuvee. Germitec operates in a competitive market with competitors including Butterfly Network, Exo, R-Zero, Zonare Medical Systems and SonoSite, among others.
- Headquarter Bordeaux, France
- Founders Clement Deshays
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$41.59 M (USD)
in 2 rounds
-
Latest Funding Round
$30 M (USD), Series B
Feb 12, 2025
-
Investors
Eurazeo
& 6 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Germitec
Germitec offers a comprehensive portfolio of products and services, including Chronos, Antigermix, and Yuvee. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers 90-second UV-C high-level disinfection for ultrasound probes.
Provides UV-C disinfection for long endocavitary probes in three minutes.
Delivers UV-C based solutions to kill pathogens on medical devices.
Unlock access to complete
Unlock access to complete
Funding Insights of Germitec
Germitec has successfully raised a total of $41.59M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $30 million completed in February 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series B — $30.0M
-
First Round
First Round
(10 May 2022)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb, 2025 | Amount | Series B - Germitec | Valuation | Eurazeo | |
| May, 2022 | Amount | Series B - Germitec | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Germitec
Germitec has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Eurazeo, Kurma Partners and Financiere Arbevel. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity and debt investments are managed across multiple sectors.
|
Founded Year | Domain | Location | |
|
Biotech startups are funded through venture capital in life sciences.
|
Founded Year | Domain | Location | |
|
Private equity investments are made in companies across diverse sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Germitec
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Germitec
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Germitec Comparisons
Competitors of Germitec
Germitec operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Butterfly Network, Exo, R-Zero, Zonare Medical Systems and SonoSite, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Handheld ultrasound devices are developed for whole-body medical imaging.
|
|
| domain | founded_year | HQ Location |
Ultrasound images are analyzed via AI-based software provided by Exo.
|
|
| domain | founded_year | HQ Location |
UV-C disinfection devices for hospital infection control are developed.
|
|
| domain | founded_year | HQ Location |
Portable ultrasound systems are developed and provided for medical use.
|
|
| domain | founded_year | HQ Location |
Hand-carried ultrasound systems for medical specialties are developed and distributed.
|
|
| domain | founded_year | HQ Location |
Deep learning-based imaging diagnostics for heart diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Germitec
Frequently Asked Questions about Germitec
When was Germitec founded?
Germitec was founded in 2005 and raised its 1st funding round 17 years after it was founded.
Where is Germitec located?
Germitec is headquartered in Bordeaux, France.
Who is the current CEO of Germitec?
Clement Deshays is the current CEO of Germitec. They have also founded this company.
Is Germitec a funded company?
Germitec is a funded company, having raised a total of $41.59M across 2 funding rounds to date. The company's 1st funding round was a Series B of $11.59M, raised on May 10, 2022.
What does Germitec do?
Germitec was founded in 2005 in Bordeaux, France, and operates in the medical device sector. UV-C light-based systems for high-level disinfection of endocavitary and external ultrasound probes are developed and supplied. Pathogens including bacteria, fungi, viruses, mycobacteria, and spores are targeted by the technology. Workflow optimization and traceability features are incorporated into the systems. A chemical-free method is employed to support healthcare operations across Europe and beyond.
Who are the top competitors of Germitec?
Germitec's top competitors include Butterfly Network, Exo and R-Zero.
What products or services does Germitec offer?
Germitec offers Chronos, Antigermix, and Yuvee.
Who are Germitec's investors?
Germitec has 7 investors. Key investors include Eurazeo, Kurma Partners, Financiere Arbevel, Turenne Groupe, and Sham.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.